Skip to search formSkip to main contentSkip to account menu

Tysabri

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
BackgroundNegative news media reports regarding potential health hazards of implanted medical devices and pharmaceuticals can… 
2015
2015
Multiple sclerosis (MS) is an immune mediated inflammatory disease that attacks myelinated axons in the central nervous system… 
2014
2014
  • C. Sheridan
  • Nature Biotechnology
  • 2014
  • Corpus ID: 205266563
Entyvio (vedolizumab), Takeda’s drug for inflammatory bowel disease (IBD), is in line to become the first integrin inhibitor to… 
Review
2009
Review
2009
Therapeutic monoclonal antibodies are potent new tools for a molecular targeted approach to modify the course of multiple… 
Review
2008
Review
2008
  • K. Honey
  • The Journal of clinical investigation
  • 2008
  • Corpus ID: 32079939
The US FDA recently approved the monoclonal antibody TYSABRI (natalizumab) for use in the treatment of adults with moderately to… 
2008
2008
  • H. Hoag
  • Nature Biotechnology
  • 2008
  • Corpus ID: 9872859
1061 that isn’t the problem, says ZymoGenetics chief executive Bruce Carter. Rather, it is because the acute hospitals that use… 
2008
2008
La Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS) ha recibido nueva informacion de seguridad concerniente al… 
2005
2005
  • E. Singer
  • Nature Medicine
  • 2005
  • Corpus ID: 12252315
The future of a promising treatment for multiple sclerosis (MS) is in question after two patients takinag the drug were diagnosed… 
2005
2005
Although the financial implications of Elan's and Biogen Idec's shock withdrawal from the market of the highly promising multiple…